Ketamine G.L. Pharma (Ketamine)

Ketamine blocks the phencyclidine site of the NMDA receptor, acting as a non‑competitive antagonist. This inhibition reduces excitatory neurotransmission and calcium influx, producing dissociative anesthesia and analgesia. The same NMDA blockade also influences neural circuits involved in mood regulation, supporting its off‑label use in resistant depression.

The exact dose is determined by the prescribing clinician based on the indication, patient characteristics, and route of administration. Dosing regimens are individualized and should follow local clinical guidelines and the prescriber’s judgment.

Safety data for ketamine during pregnancy and lactation are limited. It is generally avoided unless the potential therapeutic benefit justifies the potential risk to the fetus or infant. Clinicians should discuss risks and benefits with the patient and consider alternative treatments when possible.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and the necessary import documentation.

Compared with traditional anesthetics such as propofol, ketamine provides dissociative anesthesia while preserving airway reflexes and cardiovascular stability, making it useful in hemodynamically unstable patients. Unlike pure opioid analgesics, it offers both analgesic and anesthetic effects without significant respiratory depression at sub‑anesthetic doses.

Ketamine G.L. Pharma should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from direct sunlight, moisture and extreme temperatures. Ensure that the container remains sealed until use to maintain sterility.

Ketamine G.L. Pharma is supplied as a sterile injectable solution and can be administered intravenously or intramuscularly by a qualified healthcare professional. The route, rate of infusion or injection, and total dose are determined by the prescriber according to the clinical situation.

Serious adverse events include respiratory depression, severe hypertension or cardiac arrhythmias, neurotoxicity with prolonged exposure, and rare allergic reactions such as anaphylaxis. Continuous monitoring of airway, breathing, and cardiovascular status is essential during and after administration.

Ketamine is contraindicated in patients with known hypersensitivity to the drug, uncontrolled hypertension, severe cardiovascular disease, or a history of psychosis that may be exacerbated by dissociative effects. Caution is also advised for individuals with a history of substance abuse or those taking interacting central nervous system depressants.